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The era of industrialization has revolutionized our societies, allowing the emergence of technology
and improving our standard of living; however, after almost 200 years we are also experiencing
unwanted consequences. Mass production allows us to acquire goods more cheaply, but the quality
of products is often compromised: industrial food processing, for example, has developed strategies
to offer highly caloric and sweeter food by adding low cost-ingredients (i.e., palm oil, high-fructose
corn syrup), whose consumption correlates with the development of obesity (O’Kane, 2012). In
addition, sedentary life-styles and stressful workloads influence the rates of chronic degenerative
diseases such as diabetes, cardiovascular disease, and metabolic pathologies. Over the last decade,
many researchers have shown that metabolic disturbances such as obesity and metabolic syndrome
are risk factors for the development of dementias and even Alzheimer’s disease (AD) (Solfrizzi
et al., 2011; Emmerzaal et al., 2015). The mechanisms involved in the AD pathogenesis associated
with metabolic alterations are now becoming more understandable. In spite of this and due to the
multifactorial complexity of the pathology, more preclinical and clinical data are still needed to
understand its development.
An optimal supply of nutrients is necessary to maintain normal functioning of the brain.
Mechanistic studies, epidemiologic analyses, and randomized intervention trials have provided
insight into the positive effects of micronutrients (vitamins B, E, C, and D) as well as
docosahexaenoic acid (DHA) in helping neurons to cope with aging (Wengreen et al., 2013).
As a result, considerable attention has been given to nutraceuticals and nutritionally bioactive
compounds that can be obtained directly from the diet or supplements and have been reported
to have positive effects in animal models of AD and obesity. As an example, Concord grape juice
have shown cognitive enhancing effects in subjects with mild-cognitive-impairment (Krikorian
et al., 2010a), while blueberry supplementation has improved memory performance in older adult
(Krikorian et al., 2010b). However, more randomized controlled clinical trials are needed to
determine whether food or food supplements can slow or prevent age-related cognitive decline
or AD. The aim of this research topic is to cover a range of publications about the impact of poor
nutrition (overweight, obesity) on the development of AD and to highlight the use of nutrition as
a preventive strategy to reduce the incidence of dementias and AD. Here we describe briefly, the
articles included in this research topic.
Hsu and Kanoski have reviewed studies on the effect of the Western diet on the blood-brain-
barrier (BBB) and cognitive decline. These authors have shown that the Western diet causes BBB
disruption, and they propose this damage as one of the main factors responsible for the cognitive
impairments seen in obese animals (Hsu and Kanoski, 2014).
Panza et al. open a discussion about the term “cognitive frailty” and the vulnerability of patients
with mild cognitive and other pre-dementia syndromes to develop AD. Macro- and micronutrient
deficiencies have been related to frailty in older subjects, whereas nutrition and physical exercise
may improve cognition in frail and pre-frail states (Panza et al., 2014).
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Swaminathan and Jicha postulated in a comprehensive
review that nutrition is a disease-modifying approach against
AD development, based on preclinical and clinical studies
(Swaminathan and Jicha, 2014). In an opinion article, Santos et al.
describe the role of selenium (Se) in the antioxidant system, and
they discuss clinical and preclinical data showing that low plasma
levels of Se are associated with higher AD incidence (Santos et al.,
2014).
Micronutrients such as polyphenols have important anti-
oxidant, anti-inflammatory, and anti-carcinogenic activities.
Resveratrol is a polyphenol present in grapes, and Wang
et al. have tested its anti-amyloid properties in a mouse
model of AD. The efficacy of resveratrol and other grape
extracts was assessed in a cognitive task, and Abeta load
or Abeta-mediated synaptic toxicity was evaluated by
LTP induction in J20 transgenic mice. Resveratrol did
not show beneficial effects on these parameters, but grape
extracts did. Pasinetti’s group suggested that a combination
of several bioactive metabolites in the juice extract, not
resveratrol alone, might ameliorate AD pathology (Wang et al.,
2014).
Impaired glucose metabolism in some regions of the brain
has been observed in AD patients (Landau et al., 2012), while
a supplement of ketone bodies seems to revert this metabolic
alteration and improve cognitive performance in animal models
of AD (Kashiwaya et al., 2013). In this issue Farah reports a
clinical case study of the effect of caprylic triglyceride, a medium-
chain triglyceride that induces ketosis, in a 70-year-old man with
probable mild AD. The results provided supporting evidence that
ketogenic treatments were cognitively effective in AD (Farah,
2014). However, larger randomized clinical trials on patients
diagnosed with AD are desirable.
Qian and Ke reviewed the broad mechanism of action of
Huperzine (Hurp A) as an anti-AD agent, in addition to
its “cholinergic” mechanism of action, including clinical trials
where Hurp A treatments resulted in cognitive improvements
in patients with mild- and moderate-AD patients (Qian and Ke,
2014).
Hypo-vitaminosis has been related to cognitive decline in
the elderly population, and low vitamin D levels are critically
associated with AD (Balion et al., 2012). Annweiler and Beauchet
discussed the current threshold that defines vitamin D hypo-
vitaminosis. They suggest the threshold be standardized to
provide better-directed preventive treatment against cognitive
deterioration for those at risk due to low vitamin D (Annweiler
and Beauchet, 2014).
AD is a multifactorial pathology, where physiological and
life-style parameters may impact brain functioning. Therefore, a
holistic diagnostic assessment could offer valuable information
to predict progression to dementia. Franke and collaborators
provide evidence of the recent BrainAGE approach to predict
brain aging and risk of developing AD. Based on magnetic
resonance imaging data, the authors explore the impact of
physiological and clinical data on the risk to develop AD
in cognitively unimpaired adults. This article provides further
evidence that metabolic changes have an impact on cognitive
status, and it proposes the BrainAGE approach as an early
diagnostic tool to assess the risk of developing dementia based
on structural and functional brain aging in conjunction with
metabolic parameters (Franke et al., 2014).
Thus, accumulated evidence from preclinical and clinical
studies about the neuroprotective effects of macro- and micro-
nutrients, as well as whole food and bioactive products suggest a
path for further treatment strategies to combat this devastating
neurodegenerative disease. A holistic diagnostic approach to
detect early alterations plus preventive treatment could reduce
the incidence of AD in our current industrialized world.
Acknowledgments
We like to acknowledge Dr. Douglas Watt for his valuable
opinions and extensive knowledge that helped to improve his
revised articles. We like to thank to all reviewers that participated
in this research topic, and encouraged to improve quality of
publications. We also thank Dr. Isabel Perez-Cruz and Dorothy
Pless for proofreading the current manuscript.
References
Annweiler, C., and Beauchet, O. (2014). Vitamin D in older adults: the need to
specify standard values with respect to cognition. Front. Aging Neurosci. 6:72.
doi: 10.3389/fnagi.2014.00072
Balion, C., Griffith, L. E., Strifler, L., Henderson, M., Patterson, C., Heckman, G.,
et al. (2012). Vitamin D, cognition, and dementia; a systematic review and
meta-analysis. Neurology 79, 1397–1405. doi: 10.1212/WNL.0b013e31826c197f
Emmerzaal, T. L., Kiliaan, A. J., Gustafson, D. R., Versailles, I., and
Quentin, S. (2015). 2003-2013: a decade of body mass index, Alzheimer’s
Disease, and Dementia. J. Alzheimers Dis. 43, 739–755. doi: 10.3233/
JAD-141086
Farah, B. A. (2014). Effects of caprylic triglyceride on cognitive performance
and cerebral glucose metabolism in mild Alzheimer’s Disease: a single-
case observation. Front. Aging Neurosci. 6:133. doi: 10.3389/fnagi.
2014.00133
Franke, K., Ristow, M., and Gaser, C. (2014). Gender-specific impact of personal
health parameters on individual brain aging in cognitively unimpaired elderly
subjects. Front. Aging Neurosci. 6:94. doi: 10.3389/fnagi.2014.00094
Hsu, T. M., and Kanoski, S. E. (2014). Blood-brain barrier disruption: mechanistic
links between Western diet consumption and dementia. Front. Aging Neurosci.
6:88. doi: 10.3389/fnagi.2014.00088
Kashiwaya, Y., Bergman, C., Lee, J. H., Wan, R., King, M. T., Mughal, M.
R., et al. (2013). A ketone ester diet exhibits anxiolytic and cognition-
sparing properties, and lessens amyloid and tau pathologies in a mouse
model of Alzheimer’s disease. Neurobiol. Aging 34, 1530–1539. doi:
10.1016/j.neurobiolaging.2012.11.023
Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., and Joseph, J. A.
(2010a). Concord grape juice supplementation improves memory function in
older adults with mild cognitive impairment. Br. J. Nutr. 103, 730–734. doi:
10.1017/S0007114509992364
Krikorian, R., Shidler, M. D., Nash, T. A., Kalt, W., Vinqvist-tymchuk, M. R.,
Shukitt-hale, B., et al., (2010b). Blueberry supplementation improves memory
in older adults. J. Agri. Food Chem. 58, 3996–4000. doi: 10.1021/jf9029332
Landau, S. M., Mintun, M. A., Joshi, A. D., Koeppe, R. A., Petersen, R.
C., Aisen, P. S., et al. (2012). Amyloid deposition, hypometabolism, and
longitudinal cognitive decline. Ann. Neurol. 72, 578–586. doi: 10.1002/ana.
23650
Frontiers in Aging Neuroscience | www.frontiersin.org 2 September 2015 | Volume 7 | Article 170
Perez-Cruz and Díaz-Cintra Editorial: Nutrition and prevention of Alzheimer’s disease
O’Kane, G. (2012). What is the real cost of our food? Implications for the
environment, society and public health nutrition. Public Health Nutr. 15,
268–276. doi: 10.1017/S136898001100142X
Panza, F., Solfrizzi, V., Giannini, M., Seripa, D., Pilotto, A., and Logroscino, G.
(2014). Nutrition, frailty, and Alzheimer’s disease. Front. Aging Neurosci. 6, 1–6.
doi: 10.3389/fnagi.2014.00221
Qian, Z. M., and Ke, Y. (2014). Huperzine A: is it an effective disease-
modifying drug for Alzheimer’s disease? Front. Aging Neurosci. 6:216. doi:
10.3389/fnagi.2014.00216
Santos, J. R., Gois, A. M., Mendonça, D. M. F., and Freire, M. A.
M. (2014). Nutritional status, oxidative stress and dementia: the role
of selenium in Alzheimer’s disease. Front. Aging Neurosci. 6:206. doi:
10.3389/fnagi.2014.00206
Solfrizzi, V., Scafato, E., Capurso, C., D’Introno, A., Colacicco, A. M., Frisardi, V.,
et al. (2011). Metabolic syndrome, mild cognitive impairment, and progression
to dementia. The Italian Longitudinal Study on Aging. Neurobiol. Aging 32,
1932–1941. doi: 10.1016/j.neurobiolaging.2009.12.012
Swaminathan, A., and Jicha, G. A. (2014). Nutrition and prevention of Alzheimer’s
dementia. Front. Aging Neurosci. 6:282. doi: 10.3389/fnagi.2014.00282
Wang, J., Bi, W., Cheng, A., Freire, D., Vempati, P., Zhao, W., et al. (2014).
Targeting multiple pathogenic mechanisms with polyphenols for the treatment
of Alzheimer’s disease-experimental approach and therapeutic implications.
Front. Aging Neurosci. 6:42. doi: 10.3389/fnagi.2014.00042
Wengreen, H., Munger, R. G., Cutler, A., Quach, A., Bowles, A., Corcoran, C.,
et al. (2013). Prospective study of Dietary approaches to stop hypertension-
and mediterranean-style dietary patterns and age-related cognitive change:
the cache county study on memory, health and aging. Am. J. Clin. Nutr. 98,
1263–1271. doi: 10.3945/ajcn.112.051276
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Perez-Cruz and Díaz-Cintra. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 3 September 2015 | Volume 7 | Article 170
